Hypersensitivity treatment algorithms and standing orders provide the nurse with the opportunity to feel confident in their ability to manage hypersensitivity and enable them to intervene earlier. Early intervention may lead to better outcomes for the patient and the potential for completion of treatments versus changes to the treatment plan.

The advances in immunotherapy in cancer care are ever-changing and complex. It is integral for nurses to have current knowledge of bispecific antibody therapies in hematologic malignancies and to understand their mechanisms of action and side effect profiles to support optimal patient outcomes.

Education about the recent advances and special considerations associated with the diagnosis and management of transformed indolent lymphomas is essential to facilitate the incorporation of novel treatment options into routine clinical practice to improve clinical outcomes.

Continued education on this topic and staying informed on the most up-to-date information will always be necessary to improve the overall safety of oncology nursing professionals.